McKesson reports Q2 adjusted EPS $7.07, consensus $6.88

Reports Q2 revenue $93.7M, consensus $89.33M. “McKesson (MCK) reported record revenue of $93.7 billion, representing 21% growth compared to the previous year, and Adjusted Earnings per Diluted Share growth of 13% for the second quarter,” said Brian Tyler, chief executive officer. “Our results for the second quarter demonstrated focused execution against our strategy and operating excellence across our businesses. We saw strong growth in our U.S. Pharmaceutical segment, including our leading oncology and specialty distribution capabilities.”